Tarsus Pharmaceuticals Inc. (TARS): Price and Financial Metrics
TARS Price/Volume Stats
| Current price | $52.91 | 52-week high | $56.77 |
| Prev. close | $52.00 | 52-week low | $18.99 |
| Day low | $50.20 | Volume | 816,300 |
| Day high | $53.62 | Avg. volume | 713,039 |
| 50-day MA | $46.21 | Dividend yield | N/A |
| 200-day MA | $34.92 | Market Cap | 2.02B |
TARS Stock Price Chart Interactive Chart >
Tarsus Pharmaceuticals Inc. (TARS) Company Bio
Tarsus is a clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a range of diseases in need of better solutions, starting with Demodex blepharitis and eye care.
TARS Price Returns
| 1-mo | 14.03% |
| 3-mo | 53.32% |
| 6-mo | 100.15% |
| 1-year | 166.95% |
| 3-year | 105.48% |
| 5-year | N/A |
| YTD | 161.28% |
| 2023 | 38.13% |
| 2022 | -34.84% |
| 2021 | -45.56% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...